Post-COVID depression and its multiple factors, does Favipiravir have a protective effect? A longitudinal study of indonesia COVID-19 patients.
<h4>Background</h4>Coronavirus disease (COVID-19) not only has a long-term effect on its survivors, it also affects their quality of life, including inducing depression as a possible manifestation of central nervous system disruption. Favipiravir shows promising efficacy as an antiviral...
Main Authors: | Bumi Herman, Andrea Bruni, Ekachaeryanti Zain, Azhar Dzulhadj, Aye Chan Oo, Viwattanakulvanid |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0279184 |
Similar Items
-
Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: A longitudinal study.
by: Bumi Herman, et al.
Published: (2022-01-01) -
Longitudinal study of disease severity and external factors in cognitive failure after COVID-19 among Indonesian population
by: Bumi Herman, et al.
Published: (2023-11-01) -
Author Correction: Longitudinal study of disease severity and external factors in cognitive failure after COVID-19 among Indonesian population
by: Bumi Herman, et al.
Published: (2023-12-01) -
Does Favipiravir Reduce Mortality in Patients with COVID-19 ARDS and Severe Pneumonia?
by: Khin Zar Li Aung, et al.
Published: (2021-12-01) -
Influencing factors and gaps of blood donation knowledge among university and college students in Myanmar: a cross-sectional study
by: Pramon Viwattanakulvanid, et al.
Published: (2022-01-01)